Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
Publication

Publications

Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art

Title
Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
Type
Another Publication in an International Scientific Journal
Year
2019
Authors
Silveira, C
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Guedes, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maia, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Curral, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Coelho, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 16
Pages: 877-888
ISSN: 1738-3684
Other information
Authenticus ID: P-00R-JQZ
Abstract (EN): Multiple Sclerosis (MS) is a chronic disabling neuroinflammatory disease. Psychiatric manifestations have a high prevalence in MS patients and may worsen the 'illness progression and the patients' quality of life (QoL). Depression is a highly prevalent condition in MS patients, associated with poorer adherence to treatment, decreased functional status and QoL, and increased suicide risk. Diagnosis and treatment of this disorder is challenging because of symptom overlap. Other prevalent psychiatric comorbidities are anxiety disorders, bipolar disorder, psychotic disorders, substance misuse and personality disorders. As the illness progresses, personality changes can happen, as well as affect abnormalities. Cognitive changes occur frequently in MS patients, and affect features like processing speed, attention, learning, memory, visual spatial capabilities, and some language deficits. Disease-modifying treatments may reduce cognitive impairment because of their container action on the brain's lesion burden. Other QoL determinants such as fatigue, pain, sexual dysfunction, exercise, resilience and social support should be taken into account, in order to promote the individuals' well-being. Further studies are needed in order to elucidate the effectiveness of pharmacotherapy and more neuroimaging studies are required to clarify the relationship between structural changes and psychiatric comorbidities.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 12
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia (2019)
Another Publication in an International Scientific Journal
Trovao, N; Prata, J; VonDoellinger, O; Santos, S; Barbosa, M; Coelho, R
Hair Cortisol as a Marker of Intergenerational Heritage of War? A Study of Veterans and Their Offspring (2020)
Article in International Scientific Journal
I Castro-Vale; van Rossum, EFC; Staufenbiel, SM; Severo M; Mota Cardoso, R; Carvalho, Davide
Cognitive Impairment in Grandparents: A Systematic Review (2021)
Article in International Scientific Journal
Rafael, A; Sousa, L; Martins, S; Lia Fernandes
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-09 at 10:36:35 | Privacy Policy | Personal Data Protection Policy | Whistleblowing